HDACi decrease NK function. by Matthew Pace (2954127)

Decreased ubiquitination in the dTAK1^K156R mutant. by Merennege Dilan Anush Fernando (525297)

“…<p>(A) Mutant dTAK1^K156R showed decreased polyubiquitination when compared with dTAK1. …”

Tax expression is associated with decreased cellular motility. by Saumya Ramanayake (7879091)

Ibuprofen and diclofenac decrease proliferation. by Verena Leidgens (815986)

“…<p>Proliferation was analyzed using crystal violet staining and results were verified via the CyQuant Direct Cell Proliferation assay in HTZ-349. (A) Starting at 72 h, all ibuprofen concentrations (0.5, 1, 2 mM) resulted in significant reduction of HTZ-349 proliferation (compared to non-treated Ctrl, 95% CI, p < 0.05). 2 mM ibuprofen caused significant proliferation inhibition at 24 h (0.01 > p ≤ 0.001) and 48 h (p < 0.0001). …”

Overexpression of ATX delays retinal vascularization and decreases vessel branching. by Hiroshi Yukiura (741223)

Discrimination of rippled-spectrum patterns in noise: A manifestation of compressive nonlinearity - Fig 6 by Olga N. Milekhina (812701)

Serotonin deficiency decreases calcium transporters expression in the mammary gland on d 10 of lactation. by Jimena Laporta (383836)

Glucose depletion decreases SBPM. by David S. Tourigny (7224299)

“…<b>C)</b> Only the metabolically active D-isoform of glucose (not L-glucose) can sustain a significantly higher SBPM in physiologically-relevant conditions containing 5mM D- or L-glucose, 5mM DL-lactate (racemic mixture) and 0.22mM pyruvate. …”

Thalidomide treatment inhibits growth in RAMEC but not in RAMEC transfected with a dominant negative mutant of CUL5 (^S730ACUL5) cDNA. by Bryan Kunkler (5204327)

Rapamycin decreases phosphorylation of S6. by Adam L. Hartman (308128)

HDL decreases endothelial exocytosis. by Scott J. Cameron (838315)

Data for Fig 5D. by Xiaohua Zhang (350570)

Models of G48D, M78I, G125C, and A146V RAD52 point mutants. by Abdulaziz B. Hamid (13804692)

Effect of lysosomal hydrolysis inhibition on the decrease of PrP^Sc levels induced by CPZ or U18666A treatment. by Takeshi Yamasaki (521196)

MTM decreased angiogenic response. by Eléonore Otjacques (410361)

“…<p>CD31 immuno-staining on bone marrow sections of control mice (<b>A</b>) or 5TGM1 injected mice, treated with the vehicle solution (<b>B</b>) or with MTM (<b>C</b>). …”

Weighted odds ratios reflecting the impact of a genetically determined 10 mg/dL decrease in LDL-C on safety and efficacy endpoints. by Aeron M. Small (9617751)

“…<p>Odds ratio and 95% confidence interval is displayed for the effect of a genetically determined 10 mg/dL decrease in LDL-C on safety and efficacy endpoints for White individuals, Black individuals, Hispanic individuals, and inverse variance weighted meta-analysis of White, Black, and Hispanic populations (IVWMA). …”

Treatment with a highly reducing agent decreases ubiquitination of D_4.2R WT and D_{4.2 4KR}R mutant. by Kamila Skieterska (841014)

Decreased dCAP-D3 expression results in double strand break accumulation within retrotransposon sequence. by Andrew T. Schuster (478446)

Δ3C virus-induced lymphomas have decreased expression of E2F target genes. by James C. Romero-Masters (4112614)

Cardamonin inhibited tumor growth and decreased FASN and Raptor. by Peiguang Niu (17044532)

“…(C) Immunohistochemistry staining of Ki-67, Raptor and FASN in the xenograft tumor tissues. Scale bar: 40 μm. (D) The semiquantification of Ki-67, Raptor and FASN in the tumor tissues (<i>n = 5</i>). …”